Glycoprotein-phospho-D-mannose



Compound IDCDAMM01384
Common nameGlycoprotein-phospho-D-mannose
IUPAC name2,3,4,5,6-pentahydroxyhexanal
Molecular formulaC6H12O6

Experimental data

Retention time9.91
Adduct[M+Na]+
Actual mz203.05
Theoretical mz203.052
Error9.94
Ionizaton modePositive
Instrument typeLC-MS/MS-QTOF, spectrum predicted by MS-DIAL v4.9 integrated with MS-FINDER 3.60
Score7.4656

Identifiers and class information

Inchi keyGZCGUPFRVQAUEE-KVTDHHQDSA-N
SmilesO=CC(O)C(O)C(O)C(O)CO
SuperclassOrganic oxygen compounds
ClassOrganooxygen compounds

Pharmacokinetic properties

Number of descriptor values(#stars)3
Number of non-conjugated amine groups (#amine)0
Number of amidine and guanidine groups (#amidine)0
Number of carboxylic acid groups (#acid)0
Number of non-conjugated amide groups (#amide)0
Number of rotatable bonds (#rotor)10
Number of reactive functional groups (#rtvFG)0
Predicted central nervous system activity (CNS)-2
Molecular weight (mol_MW)180.157
Computed dipole moment(dipole)3.997
Total solvent accessible surface area (SASA)368.873
Hydrophobic component of SASA (FOSA)127.57
Hydrophilic component of SASA (FISA)241.303
Pie component of the SASA (PISA)0
Weakly polar component of the SASA (WPSA)0
Total solvent accesible volume (volume)597.797
Number of hydrogen bond donors (donorHB)4
Number of hydrogen bond acceptors (accptHB)9.5
Free energy of solvation of dipole (dip^2/V)0.0267314
Index of cohesive interaction in solids (ACxDN^.5/SA)0.0515083
Globularity descriptor (glob)0.930374
Predicted polarizability in cubic angstroms (QPpolrz)11.349
Predicted hexadecane/gas partition coefficient (QPlogPC16)6.645
Predicted octanol/gas partition coefficient (QPlogPoct)14.594
Predicted water/gas partition coefficient (QPlogPw)15.258
Predicted octanol/water partition coefficient (QPlogPo/w)-2.016
Predicted aqueous solubility (QPlogS)-0.148
Conformation-independent predicted aqueous solubility (CIQPlogS)-0.256
Predicted IC50 value for blockage of HERG K+ channels (QPlogHERG)-2.659
Predicted apparent Caco-2 cell permeability in nm/sec (QPPCaco)51.006
Predicted brain/blood partition coefficient (QPlogBB)-1.898
Predicted apparent MDCK cell permeability in nm/sec (QPPMDCK)19.836
Predicted skin permeability, log Kp (QPlogKp)-5.007
PM3 calculated ionization potential (IP(ev))10.557
PM3 calculated electron affinity (EA(eV))-0.386
Number of likely metabolic reactions (#metab)5
Prediction of binding to human serum albumin (QPlogKhsa)-1.117
Predicted qualitative human oral absorption (HumanOralAbsorption)2
Predicted human oral absorption on 0 to 100% scale (PercentHumanOralAbsorption)45.704
Solvent-accessible surface area of fluorine atoms (SAFluorine)0
Solvent-accessible surface area of amide oxygen atoms (SAamideO)0
Van der Waals surface area (PSA)135.415
Number of nitrogen and oxygen atoms (#NandO)6
Number of violations of Lipinski’s rule of five (RuleOfFive)0
Number of violations of Jorgensen’s rule of three (RuleOfThree)0

Compound-target network

Cytoscape Graph

Protein targets associated with phytocompound

Uniprot ID Gene name Target name TTD_ID Prediction source
P36544CHRNA7Neuronal acetylcholine receptor protein alpha-7 subunitT34429SwissTargetPrediction
Q4U2R8SLC22A6Solute carrier family 22 member 6 (by homology)T70680SwissTargetPrediction
Q9UHC9NPC1L1Niemann-Pick C1-like protein 1T33901SwissTargetPrediction
P43116PTGER2Prostanoid EP2 receptorT38529SwissTargetPrediction
P04035HMGCRHMG-CoA reductaseT53585SwissTargetPrediction
P11413G6PDGlucose-6-phosphate 1-dehydrogenaseT63484SwissTargetPrediction
P04062GBABeta-glucocerebrosidaseT84173SwissTargetPrediction
P43088PTGFRProstanoid FP receptorT75797SwissTargetPrediction
P53396ACLYATP-citrate synthaseT52189SwissTargetPrediction

Target associated diseases

TTD_ID Disease_ID Disease name ICD_11 Uniprot ID Gene names
T34429DI0101Corneal disease[ICD-11: 9A76-9A78]P36544CHRNA7
T34429DI0370Schizophrenia[ICD-11: 6A20]P36544CHRNA7
T70680DI0167Gout[ICD-11: FA25]Q4U2R8SLC22A6
T70680DI0206Inborn purine/pyrimidine/nucleotide metabolism error[ICD-11: 5C55]Q4U2R8SLC22A6
T70680DI0310Ocular disease[ICD-11: N.A.]Q4U2R8SLC22A6
T33901DI0188Hyper-lipoproteinaemia[ICD-11: 5C80]Q9UHC9NPC1L1
T38529DI0003Abortion[ICD-11: JA00]P43116PTGER2
T38529DI0102Coronary atherosclerosis[ICD-11: BA52]P43116PTGER2
T38529DI0121Diabetic foot ulcer[ICD-11: BD54]P43116PTGER2
T38529DI0166Glaucoma[ICD-11: 9C61]P43116PTGER2
T38529DI0356Pulmonary hypertension[ICD-11: BB01]P43116PTGER2
T38529DI0378Sexual dysfunction[ICD-11: HA00-HA01]P43116PTGER2
T38529DI0413Transplant rejection[ICD-11: NE84]P43116PTGER2
T53585DI0070Cardiovascular disease[ICD-11: BA00-BE2Z]P04035HMGCR
T53585DI0102Coronary atherosclerosis[ICD-11: BA52]P04035HMGCR
T53585DI0128Dyslipidemia[ICD-11: 5C80-5C81]P04035HMGCR
T53585DI0188Hyper-lipoproteinaemia[ICD-11: 5C80]P04035HMGCR
T53585DI0275Multiple sclerosis[ICD-11: 8A40]P04035HMGCR
T53585DI0287Myocardial infarction[ICD-11: BA41-BA43]P04035HMGCR
T53585DI0324Pain[ICD-11: MG30-MG3Z]P04035HMGCR
T63484DI0086Chronic obstructive pulmonary disease[ICD-11: CA22]P11413G6PD
T84173DI0257Metabolic disorder[ICD-11: 5C50-5D2Z]P04062GBA
T75797DI0003Abortion[ICD-11: JA00]P43088PTGFR
T75797DI0102Coronary atherosclerosis[ICD-11: BA52]P43088PTGFR
T75797DI0166Glaucoma[ICD-11: 9C61]P43088PTGFR
T52189DI0188Hyper-lipoproteinaemia[ICD-11: 5C80]P53396ACLY

Copyright © 2025